Erasca Strengthens R&D Leadership with Appointment of Internationally Recognized Medical Oncologist Charles S. Fuchs, M.D., M.P.H., as President of R&D

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/6/2026

1. ZS
2. LULU
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. NVDA
9. CIEN
10. GWRE

Go back to Erasca Strengthens R&D Leadership with Appointment of Internationally Recognized Medical Oncologist Charles S. Fuchs, M.D., M.P.H., as President of R&D
(NASDAQ: ERAS) Delayed: 16.19 -0.07 (0.43%)
Previous Close $16.26    52 Week High $ 
Open $16.04    52 Week Low $ 
Day High $16.40    P/E N/A 
Day Low $15.77    EPS $ 
Volume 2,055,085